A New Proposal: Calculating Density Factors for Drugs Using Cocoa Butter as the Standard
Author(s): Walker Heather, Sridhar Vishak, Alexander Kenneth S
Issue: Nov/Dec 2011 - Volume 15, Number 6
View All Articles in Issue
Page(s): 510-514
Download in electronic PDF format for $75
Abstract: The cacao tree, which produces cocoa beans, exists in nature as different varieties in limited geographical zones around the world. The cocoa butter which is extracted from these different geographical regions contains various percent compositions of fatty acids, namely varied ratios of palmitic, stearic, oleic, and linoleic acids. The composition of the fatty acids contributes to the density of the cocoa butter which varies from source to source. The density of cocoa butter is a key factor in calculating the weight of cocoa butter required for making suppositories. There are three methods used to determine the amount of base needed in preparing suppositories. These methods will be described and a new method proposed. The density of the cocoa butter is found to vary from 0.86 to 0.94, or as given in the United States Pharmacopeia–National Formulary, an average value of 0.9. Every source would have a different density, and this value should be used for suppository base calculations. These density factors for various drugs can be estimated by a new empirical method proposed which uses the densities and percentages of the individual fatty acid components to determine the density of the cocoa butter. This in turn will give us a true displacement factor of the base by the drug.
Related Keywords:
cacao tree varieties, cocoa butter, fatty acid composition, suppositories, density calculation, triglycerides
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
A New Proposal: Calculating Density Factors for Drugs Using Cocoa Butter as the Standard
Walker Heather, Sridhar Vishak, Alexander Kenneth S
|
Nov/Dec 2011
Pg. 510-514
|
Ketorolac tromethamine and Ketoprofen suppositories: release profiles and bioavailability of cocoa butter base formula in rabbits
Zia Hossein, Rashed Suzette F, Quadir Mohammed, Needham Thomas E, Squillante Emilio
|
Sep/Oct 1998
Pg. 390-393
|
Taste Masking Study of Cocoa Butter Fast Melt Tablet (FMT) Formulations Containing Memantine Hydrochloride
Liew Kai Bin, Chew Yik Ling, Uddin ABM Helal, Lee Siew-Keah, Lakshminarayanan Vijayakumar, Janakiraman Ashok Kumar, Khalid Syed Haroon, Ramanunny Arya Kadukkattil, Xia Yang
|
Nov/Dec 2024
Pg. 502-508
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 304-309
|
Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding
Allen Loyd V Jr
|
May/Jun 2018
Pg. 206-217
|
Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds
Alexander Kenneth S, Baki Gabriella, Hart Christine, Hejduk Courtney, Chillas Stephanie
|
Nov/Dec 2013
Pg. 512-514
|
Compounded Suppositories and Pharmaceutical Care
Duncan-Hewitt Wendy, Rains John
|
Mar/Apr 1997
Pg. 93-99
|
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 446-466
|
Progesterone Vaginal Suppositories (Fatty Acid Base)
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 63
|
Progesterone Vaginal Suppositories (Fatty Acid Base)
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 65
|
Isoniazid Release from Suppositories Compounded with Selected Bases
Hudson Kristofer C, Asbill C Scott, Webster Andrew A
|
Sep/Oct 2007
Pg. 433-437
|
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
|
Jan/Feb 2013
Pg. 74-85
View Sample |
Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 309-310
|
Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 466-467
|
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer
Kramer Mark A, Grilley Bambi J
|
Jul/Aug 2002
Pg. 271-273
|
Suppository Displacement Factor
Allen Loyd V Jr
|
Jan/Feb 1997
Pg. 39
|
Calculations
Prince Shelly J
|
Jul/Aug 2003
Pg. 294
|
Basics: Hollow-type Suppositories
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 302-307
|
Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations
|
Jan/Feb 2025
Pg. 38-39
|
Standard Operating Procedure: Compounding with Concentrated Acids
Allen Loyd V Jr
|
Jan/Feb 2005
Pg. 61
|
Return to Top |